Scopolamine Trandermal System (Perrigo New York Inc)
Welcome to the PulseAid listing for the Scopolamine Trandermal System drug offered from Perrigo New York Inc. This Anticholinergic [EPC],Cholinergic Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Perrigo New York Inc |
NON-PROPRIETARY NAME: | scolopamine transdermal system |
SUBSTANCE NAME: | SCOPOLAMINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Anticholinergic [EPC],Cholinergic Antagonists [MoA] |
ROUTE: | TRANSDERMAL |
DOSAGE FORM: | PATCH, EXTENDED RELEASE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2017-06-13 |
END MARKETING DATE: | 0000-00-00 |
Scopolamine Trandermal System HUMAN PRESCRIPTION DRUG Details:
Item Description | Scopolamine Trandermal System from Perrigo New York Inc |
LABELER NAME: | Perrigo New York Inc |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 1(mg/1) |
START MARKETING DATE: | 2017-06-13 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 45802-580_f910c1ab-1905-4881-ae76-e979387b19c4 |
PRODUCT NDC: | 45802-580 |
APPLICATION NUMBER: | ANDA078830 |
Other SCOPOLAMINE Pharmaceutical Manufacturers / Labelers: